Finance
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
I
Investing.com
April 30, 2026·1 min read
GM
FinanceAmgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Original article
Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug
Published by Investing.com